Albumin assays and clinical decision-making in nephrotic syndrome patients

Kidney Int. 2019 Jul;96(1):248-249. doi: 10.1016/j.kint.2019.03.025.

Authors

Joris R Delanghe¹, Marijn M Speeckaert², Sigurd E Delanghe³, Marc L De Buyzere³

Affiliations

¹ Department of Diagnostic Sciences, Ghent University, Ghent, Belgium. Electronic address: joris.Delanghe@ugent.be.
² Department of Internal Medicine, Ghent University, Ghent, Belgium; Research Foundation Flanders, Brussels, Belgium.
³ Department of Internal Medicine, Ghent University, Ghent, Belgium.

PMID: 31229037
DOI: 10.1016/j.kint.2019.03.025

No abstract available

Publication types

Letter
Comment

MeSH terms

Clinical Decision-Making
Humans
Nephrotic Syndrome*
Serum Albumin

Substances

Serum Albumin